Skip to main content
. 2020 May 8;12(5):844–858. doi: 10.4168/aair.2020.12.5.844

Fig. 1. Flow diagram of study progression.

Fig. 1

AIT, allergen-specific immunotherapy; NPT, nasal provocation test; RQLQ, rhinoconjunctivitis quality of life questionnaire; IgE, immunoglobulin E; sIgE, specific immunoglobulin E; FeNO, fractional exhaled nitric oxide; VAS, visual analogue scale.